Quantcast
Home / Opinion / Commentary / Senate bill limits choices, could upend drug benefits marketplace (access required)

Senate bill limits choices, could upend drug benefits marketplace (access required)

Congress should seek to increase competition to lower the costs of prescription drugs, rather than stripping away plan sponsor and employer choice from their health care contracting decisions and handing that authority to the government. We can do better, and look forward to working with Arizona’s lawmakers to develop solutions that will preserve choices for plan sponsors and the individuals they represent.

Leave a Reply

Your email address will not be published. Required fields are marked *

*

 

x

Check Also

needle-620

State should amend needle exchange law to combat HIV

The Centers for Disease Control and Prevention estimate 40,000 new cases of HIV every year, and a major source of these cases is needle sharing among non-medical users of IV drugs.